Listed below are the Topics in Antiviral Medicine Editorial Board members and their financial relationships with commercial interests within the past 12 months from the date of disclosure. Members of the TAM Editorial Board are compensated for their work on the journal.


Editor in Chief

Douglas D. Richman, MD
Professor of Pathology and Medicine
University of California San Diego
San Diego, California

Dr Richman has been a consultant to Antiva Biosciences, Chimerix, Gilead Sciences, Inc, and Monogram Biosciences, Inc. (Updated 07/20/18)


Members

Constance A. Benson, MD
Professor of Medicine
University of California San Diego
San Diego, California

Dr Benson has served on a data and safety monitoring board for GlaxoSmithKline/ViiV Healthcare. She has received research grants awarded to her institution from Gilead Sciences, Inc. Her spouse has served as a consultant to CytoDyn, Pfizer, and Vir Biotechnology; received grant support from Gilead Sciences, Inc; and holds stock or stock options in Antiva Biosciences and CytoDyn. (Updated 07/24/18)

Martin S. Hirsch, MD
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Dr Hirsch has no relevant financial affiliations to disclose. (Updated 09/12/18)